Financials
- Market Capitalization 199.06 M
- Employee 146
- Founded 2002
- CEO John Nicols
- Website www.codexis.com
- Headquarter Delaware, United States
- FIGI BBG000RN0GZ5
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.26
売上高対価格比率
2.02
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3612 | RNA Atrium Therapeutics, Inc. - Common Stock | 12.43 USD | +1.72% | -6.26% | +0.24% | -82.33% | 212.62 M USD | ||
| 3619 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 73.64 USD | -0.37% | -3.17% | +0.88% | +829.80% | 205.17 M USD | ||
| 3628 | NKTX Nkarta, Inc. - Common Stock | 2.67 USD | -4.30% | -23.05% | -10.70% | +41.27% | 191.03 M USD | ||
| 3631 | IMUX Immunic, Inc. - Common Stock | 15.22 USD | +3.96% | -1.55% | +9.03% | +1690.59% | 207.32 M USD |